Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6354
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis ; volume:11 ; number:6 ; day:25 ; month:11 ; year:2009 ; pages:1-6 ; date:12.2009
Arthritis Research & Therapy ; 11, Heft 6 (25.11.2009), 1-6, 12.2009
- Contributor
-
Mulleman, Denis
Méric, Jean-Camille
Paintaud, Gilles
Ducourau, Emilie
Magdelaine-Beuzelin, Charlotte
Valat, Jean-Pierre
Goupille, Philippe
SpringerLink (Online service)
- DOI
-
10.1186/ar2867
- URN
-
urn:nbn:de:1111-2016050313870
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mulleman, Denis
- Méric, Jean-Camille
- Paintaud, Gilles
- Ducourau, Emilie
- Magdelaine-Beuzelin, Charlotte
- Valat, Jean-Pierre
- Goupille, Philippe
- SpringerLink (Online service)
Other Objects (12)
Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment
Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis
The effects of infliximab therapy on the serum proteome of rheumatoid arthritis patients
The Effectiveness of Intravenous Golimumab Administered Directly After Infliximab in Rheumatoid Arthritis Patients
74-week follow-up of safety of infliximab in patients with refractory rheumatoid arthritis
Pneumococcal polyarticular septic arthritis after a single infusion of infliximab in a rheumatoid arthritis patient: a case report
Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
Peripheral blood derived gene panels predict response to infliximab in rheumatoid arthritis and Crohn's disease
Effect of infliximab on mRNA expression profiles in synovial tissue of rheumatoid arthritis patients
Rheumatoid arthritis
Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases
Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept
Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment
Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis
The effects of infliximab therapy on the serum proteome of rheumatoid arthritis patients
The Effectiveness of Intravenous Golimumab Administered Directly After Infliximab in Rheumatoid Arthritis Patients
74-week follow-up of safety of infliximab in patients with refractory rheumatoid arthritis
Pneumococcal polyarticular septic arthritis after a single infusion of infliximab in a rheumatoid arthritis patient: a case report
Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
Peripheral blood derived gene panels predict response to infliximab in rheumatoid arthritis and Crohn's disease
Effect of infliximab on mRNA expression profiles in synovial tissue of rheumatoid arthritis patients
Rheumatoid arthritis
Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases
Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept
Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment
Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis
The effects of infliximab therapy on the serum proteome of rheumatoid arthritis patients
The Effectiveness of Intravenous Golimumab Administered Directly After Infliximab in Rheumatoid Arthritis Patients
74-week follow-up of safety of infliximab in patients with refractory rheumatoid arthritis
Pneumococcal polyarticular septic arthritis after a single infusion of infliximab in a rheumatoid arthritis patient: a case report
Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
Peripheral blood derived gene panels predict response to infliximab in rheumatoid arthritis and Crohn's disease
Effect of infliximab on mRNA expression profiles in synovial tissue of rheumatoid arthritis patients
Rheumatoid arthritis
Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases